These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pleuropericarditis related to the use of mesalamine. Gujral N, Friedenberg F, Friedenberg J, Gabriel G, Kotler M, Levine G. Dig Dis Sci; 1996 Mar; 41(3):624-6. PubMed ID: 8617147 [No Abstract] [Full Text] [Related]
5. Acute pleuropericarditis in a patient with primary Sjögren's syndrome and quiescent ulcerative colitis in longstanding 5-aminosalicylic acid therapy. Qanneta R, García Pardo G, Florit Serra L. J Crohns Colitis; 2013 Nov; 7(10):e506-7. PubMed ID: 23768863 [No Abstract] [Full Text] [Related]
8. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine. Nakajima H, Munakata A, Yoshida Y. J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870 [Abstract] [Full Text] [Related]
18. [Cardio vascular disease associated with ulcerative colitis]. Iizuka B, Yamagishi N, Honma N, Hayashi N. Nihon Rinsho; 1999 Nov; 57(11):2540-5. PubMed ID: 10572427 [Abstract] [Full Text] [Related]
19. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity. Bresci G, Carrai M, Venturini G, Gambardella L. Int J Tissue React; 1990 Nov; 12(4):243-6. PubMed ID: 1980911 [Abstract] [Full Text] [Related]